NATERA, INC. Payments to Acquire Debt Securities, Available-for-sale
NATERA, INC. (NTRA) reported Payments to Acquire Debt Securities, Available-for-sale of $122.01 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-02-27
- NATERA, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2024-12-31 was $0.00.
- NATERA, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2024-09-30 was $49.20M.
- NATERA, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- NATERA, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2022-09-30 was $6.99M, a 98.84% decline year-over-year.
- NATERA, INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $122.01M, a 24.12% increase from fiscal 2023.
- NATERA, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $98.30M, a 13.06% increase from fiscal 2022.
- NATERA, INC. payments to acquire debt securities, available-for-sale for fiscal 2022 was $86.95M, a 90.08% decline from fiscal 2021.
- NATERA, INC. payments to acquire debt securities, available-for-sale for fiscal 2021 was $876.10M, a 27.85% increase from fiscal 2020.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $49.20M derived: sum of 2 quarters · filed 2026-02-27 | $122.01M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $49.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $122.01M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $72.81M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $98.30M 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.99M derived: sum of 2 quarters · filed 2025-02-28 | $61.97M derived: sum of 3 quarters · filed 2025-02-28 | $86.95M 10-K · filed 2025-02-28 |
| 2022-09-30 | $6.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $61.97M derived: sum of 2 quarters · filed 2023-11-09 | $86.95M 10-Q · filed 2023-11-09 | $288.67M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $54.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $79.96M 10-Q · filed 2023-08-04 | $281.68M derived: sum of 3 quarters · filed 2024-02-29 | $885.00M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $24.98M 10-Q · filed 2023-05-10 | $226.70M derived: sum of 2 quarters · filed 2024-02-29 | $830.02M derived: sum of 3 quarters · filed 2024-02-29 | $858.05M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $201.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $805.04M derived: sum of 2 quarters · filed 2024-02-29 | $833.07M derived: sum of 3 quarters · filed 2024-02-29 | $876.10M 10-K · filed 2024-02-29 |
| 2021-09-30 | $603.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $631.35M derived: sum of 2 quarters · filed 2022-11-09 | $674.37M 10-Q · filed 2022-11-09 | $880.57M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $28.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $71.05M 10-Q · filed 2022-08-05 | $277.26M derived: sum of 3 quarters · filed 2023-03-01 | $490.15M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $43.02M 10-Q · filed 2022-05-06 | $249.23M derived: sum of 2 quarters · filed 2023-03-01 | $462.12M derived: sum of 3 quarters · filed 2023-03-01 | $674.39M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $206.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $419.10M derived: sum of 2 quarters · filed 2023-03-01 | $631.36M derived: sum of 3 quarters · filed 2023-03-01 | $685.24M 10-K · filed 2023-03-01 |
| 2020-09-30 | $212.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $425.16M derived: sum of 2 quarters · filed 2021-11-05 | $479.04M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $212.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $266.14M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $53.88M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $446.63M 10-K · filed 2022-02-25 | |||
| 2019-09-30 | $197.01M 10-Q · filed 2020-11-06 | $359.19M derived: sum of 2 quarters · filed 2020-11-06 | $377.81M derived: sum of 3 quarters · filed 2020-11-06 | |
| 2019-06-30 | $162.18M 10-Q · filed 2020-08-07 | $180.80M derived: sum of 2 quarters · filed 2020-08-07 | ||
| 2019-03-31 | $18.63M 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $170.27M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $272.82M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |